🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Celyad Oncology SA (EBR:CYAD)
Belgium flag Belgium · Delayed Price · Currency is EUR
0.1610
-0.0140 (-8.00%)
Nov 19, 2026, 5:35 PM CET

Celyad Oncology Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7829161179
Market Cap Growth
-19.50%-74.20%82.56%41.33%-85.61%-13.96%
Enterprise Value
782412-176
Last Close Price
0.160.170.710.390.513.52

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
2.349.17----
PS Ratio
1029.52362.36158.59158.40--
PB Ratio
5.743.1257.722.562.651.82
P/TBV Ratio
5.803.1460.452.582.9610.00

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-364.31130.42114.87--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--1.770.170.060.06
Net Debt / Equity Ratio
-0.10-0.70-6.45-0.94-2.82-0.63
Net Debt / EBITDA Ratio
-0.161.120.580.660.491.03
Net Debt / FCF Ratio
0.020.250.580.370.431.01
Asset Turnover
0.000.000.010.01--
Quick Ratio
0.911.381.793.341.312.34
Current Ratio
0.941.922.293.791.422.48
Return on Equity (ROE)
-56.33%-170.92%-159.08%-170.72%-71.05%
Return on Assets (ROA)
14.51%-13.40%-27.99%-33.14%-31.92%-23.32%
Return on Capital Employed (ROCE)
66.70%-61.50%-82.90%-71.50%-273.90%-41.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
42.73%10.91%-19.74%-52.29%-358.06%-33.38%
FCF Yield
-70.86%-90.68%-19.26%-99.65%-246.08%-33.97%
Buyback Yield / Dilution
-15.71%-11.68%-61.06%-13.84%-44.80%-11.92%